This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Safety and Effectiveness of Sculptra Aesthetic for Correction of Nasolabial Folds.

Sponsored by Galderma R&D

About this trial

Last updated 3 years ago

Study ID

43USSA1705

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
22+ Years
All
All

Trial Timing

Ended 5 years ago

What is this trial about?

This study has been designed to evaluate the safety of Sculptra Aesthetic as a single regimen for correction of Nasolabial Fold (NLF) contour deficiencies after changes in reconstitution and injection procedures compared to the approved label.

What are the participation requirements?

Yes

Inclusion Criteria

- Intent to undergo correction of both left and right NLFs with a Wrinkle Assessment Scale (WAS) score of greater than or equal to 2 (shallow wrinkles) to less than or equal to 4 (deep wrinkles) as assessed on Day 1 (and also at screening, if screening was performed prior to Day 1) by the Blinded Evaluator. A one grade difference between sides is allowed at inclusion.

No

Exclusion Criteria

- Previous tissue augmenting therapy, contouring or revitalization treatment in or near the treatment area with any filler prior to Baseline visit.

1. Collagen, Hyaluronic Acid- 12 months
2. Calcium Hydroxyapatite (CaHa), Poly-L-lactic Acid (PLLA) or permanent (non-biodegradable)- Prohibited

- Known/previous allergy or hypersensitivity to any of the Sculptra Aesthetic constituents.

Locations

Location

Status